Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
<p>With large-scale genome sequencing initiatives underway, vast amounts of genomic data are being generated. Results—including secondary findings (SF)—are being returned, although policies around generation and management remain inconsistent. In order to inform relevant policy, it is essenti...
Asıl Yazarlar: | Mackley, M, Blair, E, Parker, M, Taylor, J, Watkins, H, Ormondroyd, E |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
Nature Publishing Group
2018
|
Benzer Materyaller
-
Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
Yazar:: Ormondroyd, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
From genotype to phenotype: Clinical assessment and participant perspective of a secondary genomic finding associated with long QT syndrome
Yazar:: Mackley, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
“Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project
Yazar:: Ormondroyd, E, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
Insights from early experience of a Rare Disease Genomic Medicine Multidisciplinary Team: a qualitative study
Yazar:: Ormondroyd, E, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
A clinical and ethical evaluation of secondary findings in the era of clinical whole-genome sequencing
Yazar:: Mackley, M
Baskı/Yayın Bilgisi: (2017)